Press Releases

The Spectranetics Corporation (Nasdaq:SPNC), a leading maker of medical devices used in minimally invasive cardiovascular procedures, today announced the appointment of Kimberly McIntosh Bridges as Senior Vice President, Sales and Marketing, Vascular Intervention, effective August 30, 2013. She will report to Scott Drake, President and Chief Executive Officer, and will be located at the company's global headquarters in Colorado Springs, CO.

Christopher Adams, M.D., a cardiology fellow with the department of cardiology, Joan C. Edwards School of Medicine, recently received the James Willerson Clinical Award Competition for Residents and Fellows from the International Academy of Cardiovascular Sciences (IACS).  The award was established to promote, encourage and recognize young talents in cardiovascular science, medicine and surgery.

Christopher Adams, M.D., a cardiology fellow with the department of cardiology, Joan C. Edwards School of Medicine, recently received the James Willerson Clinical Award Competition for Residents and Fellows from the International Academy of Cardiovascular Sciences (IACS).  The award was established to promote, encourage and recognize young talents in cardiovascular science, medicine and surgery. 

Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on Infraredx’s exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan, the world’s largest intravascular imaging market. In conjunction with the investment, a member of Nipro’s management team will join Infraredx’s board of directors.

Health First is pleased to announce Sharon Cochran, RN, MSN has been named Administrative Director of Cardiovascular Services for Health First Holmes Regional Medical Center. Cochran will provide leadership to nursing units, Cardiology Services and Respiratory Services. She will also work with Cardiovascular Surgical Services.

The Hypertrophic Cardiomyopathy (HCM) Center of the Minneapolis Heart Institute Foundation, directed by Dr. Barry J. Maron, will host the fifth international summit on HCM: A Contemporary Treatable Disease on Sept. 27-29 at the Hyatt Regency Hotel in Minneapolis, Minn.

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

For millions of Americans, simply walking to the mailbox can cause unbearable leg pain as muscles scream for more blood and oxygen.

A cardiovascular research team from Beth Israel Deaconess Medical Center (BIDMC) and Brigham and Women's Hospital (BWH), led by BIDMC Principal Investigator Saumya Das, MD, PhD, has been awarded a $4 million Common Fund grant from the National Institutes of Health (NIH) as part of a newly formed program on Extracellular RNA Communication. The five-year grant will focus on identifying microRNA biomarkers in heart disease.

Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the company's President/CEO, has been appointed to serve on Workforce Florida's Board of Directors for a four year term by Florida Governor Rick Scott. Tomas is one of 15 Floridians appointed to the Board of Directors. Workforce Florida is charged with overseeing the state's workforce system and developing strategies that will improve the state's business environment while supporting its economy (www.EmployFlorida.com).

World-renowned cardiologist and researcher Valentin Fuster, MD, PhD, MACC, has been named editor-in-chief of the Journal of the American College of Cardiology,  the nation’s leading source of  clinical information in the area of cardiovascular medicine and the flagship journal of the American College of Cardiology.

Emphasizing the importance of establishing routine objective, external reviews of cardiac cath lab (CCL) processes, Ralph G. Brindis, MD, MPH, MACC, FSCAI, Clinical Professor of Medicine, Department of Medicine & the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, Senior Medical Officer, External Affairs, ACC National Cardiovascular Data Registry, Past President, American College of Cardiology, challenged participants during the 2013 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in Orlando, FL by asking: "How do you know that your CCL practices are okay?"

Rady Children’s Hospital-San Diego today celebrated the grand opening of its new state-of-the-art Cardiovascular Intensive Care Unit (CVICU).

The new American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) Surgical Risk Calculator is a revolutionary new tool that quickly and easily estimates patient-specific postoperative complication risks for almost all operations, according to research findings appearing online in the Journal of the American College of Surgeons. The study will be published in a print edition of the Journal later this year.

The Mayo Clinic Board of Trustees has named Jeff Bolton Mayo Clinic's next vice president, administration and chief administrative officer and recognized two recipients of Mayo Clinic named professorships.

The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

Southampton Hospital hosted a ground-breaking ceremony on August 12, 2013 to celebrate the beginning of its new Audrey and Martin Gruss Heart and Stroke Center and to honor the Gruss’ extraordinary gift of $5 million to the new facility at the Hospital.  When completed, the Center will provide stroke treatment and carotid stents as needed and will consolidate a broad spectrum of new and sophisticated diagnostic and treatment capabilities with existing cardiovascular programs and services. 

An algorithm capable of diagnosing heart rhythm with just 3 seconds' worth of signal, and the demonstration that it is possible to come up with the diagnosis without stopping cardiac massage, constitute the types of solutions and proposals being developed by researchers in the Signal and Communications Group of the Faculty of Engineering in Bilbao (UPV/EHU-University of the Basque Country).

Cardiologists at the University of Rochester Medical Center are launching a new study in an effort to improve the treatment of a very common form of heart disease in the Asian population.

As randomized controlled trials and systematic reviews in healthcare have grown in their number and influence, there is an increasing need to identify those studies which should change how physicians treat their patients – and those which should not. F1000Trials extends the widely-recognized system of peer-nominated experts identifying great research in biology and medicine pioneered by F1000Prime. In F1000Trials, the F1000 Faculty Members provide expert assessment of newly published trial articles and write short reviews, recommending the most noteworthy by assigning star ratings and highlighting those which change clinical practice.

The Texas Council on Cardiovascular Disease (CVD) and Stroke, in conjunction with the CVD & Stroke Program of the Texas Department of State Health Services, will present Healthy Lubbock with the Department of State Health Services 2013 Cardiovascular Health Promotions Award.